ArticleBreast cancer research : BCR2023

Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low.

Xi E Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.